Publication Name	World Journal of Clinical Oncology
Manuscript ID	93746
Country	United States

Received	2024-03-04 23:43
Peer-Review Started	2024-03-04 23:43
To Make the First Decision
Return for Revision	2024-05-11 08:35
Revised	2024-05-22 23:03
Second Decision	2024-06-11 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-06-11 09:18
Articles in Press	2024-06-11 09:18
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-07-09 07:36
Publish the Manuscript Online	2024-07-16 06:17

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Systematic Reviews
Article Title	Investigating the therapeutic efficacy of psilocybin in advanced cancer patients: A comprehensive review and meta-analysis
Manuscript Source	Unsolicited Manuscript
All Author List	Husam Bader, Husam Farraj, Joud Maghnam and Yazan Abu Omar
Funding Agency and Grant Number
Corresponding Author	Husam Bader, MD, Assistant Professor, Department of Internal Medicine, University of Michigan, 1500 E Medical Center Dr, Ann Arbor, MI 48109, United States. h.bader87@gmail.com
Key Words	Meta analysis; Systemic review; Psilocybin; Advanced cancer; Quality of life
Core Tip	Psilocybin-assisted therapy shows promising results in improving quality of life, pain control, and anxiety relief for patients with advanced cancer. This systematic review and meta-analysis of 7 studies involving 132 participants demonstrated significant reductions in anxiety symptoms and sustained improvements in psychological well-being following psilocybin therapy. These findings highlight the potential therapeutic benefits of psilocybin in palliative care settings.
Publish Date	2024-07-16 06:17
Citation	<p>Bader H, Farraj H, Maghnam J, Abu Omar Y. Investigating the therapeutic efficacy of psilocybin in advanced cancer patients: A comprehensive review and meta-analysis. <i>World J Clin Oncol</i> 2024; 15(7): 908-919</p>
URL	https://www.wjgnet.com/2218-4333/full/v15/i7/908.htm
DOI	https://dx.doi.org/10.5306/wjco.v15.i7.908

Full Article (PDF)	WJCO-15-908-with-cover.pdf
PRISMA 2009 Checklist	93746-PRISMA-2009-Checklist.pdf
Manuscript File	93746_Auto_Edited-YJP.docx
Answering Reviewers	93746-answering-reviewers.pdf
Audio Core Tip	93746-audio.m4a
Biostatistics Review Certificate	93746-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form	93746-conflict-of-interest-statement.pdf
Copyright License Agreement	93746-copyright-assignment.pdf
Peer-review Report	93746-peer-reviews.pdf
Scientific Misconduct Check	93746-scientific-misconduct-check.png
Scientific Editor Work List	93746-scientific-editor-work-list.pdf
CrossCheck Report	93746-crosscheck-report.png
CrossCheck Report	93746-crosscheck-report.pdf